Navigation Links
New England Patriots Offensive Line Wins Second Annual Madden Most Valuable Protectors Award Presented by Prilosec OTC®

CINCINNATI, Feb. 3, 2011 /PRNewswire/ -- The New England Patriots added another noteworthy accomplishment to an already impressive 2010 regular season when it was announced the Patriots offensive line has been selected as the winner of the 2010 Madden Most Valuable Protectors Award, presented by Prilosec OTC®.  Pro Football Hall of Fame coach JOHN MADDEN and Prilosec OTC presented the award, which honors the NFL's best offensive line, to New England's front five during a press event in North Texas earlier today.  Accepting the trophy on behalf of the New England Patriots were offensive linemen Dan Koppen, Dan Connolly and Mark LeVoir.

As a proud six-year sponsor of the NFL, Prilosec OTC presents the Madden Most Valuable Protectors Award to recognize the fundamental role offensive linemen play in their teams' success by providing reliable protection day in and day out, just as Prilosec OTC can provide 24-hour heartburn protection when used as directed(1).  The award is based on a combination of criteria including offensive line statistics – sacks allowed, rushing and passing yardage, time of possession, O-line penalties, 3rd and 4th down conversion percentages and red zone scoring conversions, fan voting and coach Madden's own personal observations throughout the season.  

The Patriots players providing the powerful protection up front this season were tackles MATT LIGHT (Purdue) and SEBASTIAN VOLLMER (Houston); guards DAN CONNOLLY (Southeast Missouri State) and LOGAN MANKINS (Fresno State); and center DAN KOPPEN (Boston College)..  Adding depth on the Patriots offensive line were, MARK LEVOIR (Notre Dame), STEPHEN NEAL (Cal State-Bakersfield), RICH OHRNBERGER (Penn State), QUINN OJINNAKA (Syracuse) and RYAN WENDELL (Fresno State).

"The offensive line doesn't always catch the fans' attention, so Prilosec OTC and I created this award to recognize the guys who provide the critical run blocking and pass protection," said John Madden.  "All season long, these guys proved they had the mental and physical toughness that enabled the Patriots offense to put up impressive numbers on the ground and in the air."

Throughout the regular season, Coach Madden closely tracked the top offensive lines in the NFL and narrowed the field of contenders to five (5) finalists: the ATLANTA FALCONS, KANSAS CITY CHIEFS, NEW ORLEANS SAINTS, NEW YORK GIANTS and the NEW ENGLAND PATRIOTS.  Each of the finalists had been recognized at least once this season by Madden as an "O-Line of the Week" for their consistent and reliable protection.

Contributing to their Madden Most Valuable Protectors Award win, the Patriots offensive line provided reliable run blocking and powerful pass protection for the top-ranked offense in the NFL. The Patriots led the league in points per game (32.4) and ranked 4th in sacks allowed (25). They finished 8th in average yards (363.8), ranked 9th in average rushing yards (123.3) and ranked 11th in passing yards per game (240.4).

Weighing 102 pounds, The Madden Most Valuable Protectors Award trophy is the heaviest trophy in NFL history and is a tribute to the NFL's toughest protectors on the offensive line.

NFL fans who want powerful can provide 24-hour protection against frequent heartburn(1), which is heartburn that occurs two or more days a week, can take a 14-day course of Prilosec OTC to maximize game day fun(2). Fans can go to for more information on the 14-day challenge and to see how two of the league's toughest offensive linemen – Giants' David Diehl and Vikings' Anthony Herrera – protected themselves this season against heartburn.

All player participation will be facilitated by NFL PLAYERS, the licensing and marketing subsidiary of the NFL Players Association.  Prilosec OTC is the Official Heartburn Remedy Sponsor of the NFL.


PRILOSEC OTC® is the #1 physician recommended OTC acid reducer(3) in the U.S. for the period of April 2009 through March 2010, the #1 Pharmacist recommended OTC Heartburn medicine(4) and the first of a class of OTC heartburn medicines that treats frequent heartburn with just one pill a day. Prilosec OTC® is a leading frequent heartburn medicine that can work for 24 hours with one pill a day by directly shutting down many acid pumps in your stomach when used as directed for 14 days for treating frequent heartburn. For more information about PRILOSEC OTC®, visit PRILOSEC OTC® is available over-the-counter through an alliance between P&G and AstraZeneca.

About Procter and Gamble

Four billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Pampers®, Tide®, Ariel®, Always®, Whisper®, Pantene®, Mach3®, Bounty®, Dawn®, Gain®, Pringles®, Charmin®, Downy®, Lenor®, Iams®, Crest®, Oral-B®, Duracell®, Olay®, Head & Shoulders®, Wella®, Gillette®, Braun® and Fusion®. The P&G community includes approximately 135,000 employees working in about 80 countries worldwide. Please visit for the latest news and in-depth information about P&G and its brands.


Formed in 1994, NFL PLAYERS is the licensing and marketing subsidiary of the NFL Players Association. Representing more than 1,800 active and many memorable former NFL players, NFL PLAYERS "takes the helmets off" the players and markets them as personalities as well as professional athletes. Through an exclusive sponsorship agreement between the organization and the NFL, players are integrated into NFL sponsor activation programs. In addition, NFLPLAYERS.COM, the company's official Web site, is part of the NFL Internet Network. Each year, NFL PLAYERS negotiates and facilitates extensive player marketing opportunities for players. NFL PLAYERS activities include retail licensing, corporate sponsorships and promotions, special events, radio and television projects, publishing and Internet. For more information, please visit NFLPLAYERS.COM.

(1) It's possible while taking Prilosec OTC. Use as directed for 14 days to treat frequent heartburn.

(2) May take 1 to 4 days for full effect

(3) "Wolters Kluwer: OTC Acid Reducer Category."

(4) "Based on Pharmacy Times 2010 Survey."

SOURCE Procter and Gamble
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pescatello Elected to Head New England Biotech Association in 2011-12
2. Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine
3. Study Published in New England Journal of Medicine Shows Nplate® Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP
4. Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
5. New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome
6. New England Biolabs Receives Award to Develop Novel Enzymatic Reagents for Epigenetic Studies
7. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
8. New England Biolabs Launches NEBNext™ Quick DNA Sample Prep Reagent Sets for Use With Roche/454 Next Generation Sequencing Platforms
9. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
10. Whistleblower Lawyers Comment on New England Journal of Medicine Study
11. STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine
Post Your Comments:
(Date:11/26/2015)... -- Research and Markets ( ) has announced the ... to 2019 - Rise in Cardiac Disorders and Growing Awareness ... their offering. Boston scientific ... scientific and others. --> The market is ... Boston scientific and others. ...
(Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the German Drugs ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... of the "Self Administration of High Viscosity ... ) has announced the addition of ... report to their offering. --> ... the addition of the "Self Administration of ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... 26, 2015 , ... Indosoft Inc., developer and distributor of the world-class Asterisk ... system efficiency and reliability. , The new Q-Suite 6 platform is based on the ... locking itself into a specific piece of software for many key components of the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of the ... stellar workplace culture with the company’s Cincinnati office being named a finalist among ... was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best ...
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health Partners, ... new Wimbledon Athletics Facebook page to educate the public, parents and ... abnormalities. About 2,000 people under the age of 25 die from sudden cardiac ...
(Date:11/25/2015)... ... ... Beddit® has launched a new Android app for use with ... more intuitive SleepScore™ that rates sleep quality on a 100-point scale and makes it ... a proprietary algorithm. Beddit analyzes the data to provide an easy to understand scientific ...
Breaking Medicine News(10 mins):